カレントテラピー　32-11　サンプル page 24/36

このページは カレントテラピー　32-11　サンプル の電子ブックに掲載されている24ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　32-11　サンプル

52 Current Therapy 2014 Vol.32 No.111104Disease Prognosis Consortium：Associations of kidney diseasemeasures with mortality and end-stage renal disease in individualswith and without diabetes：a meta-analysis. Lancet380：1662-1673, 20127）日本腎臓学会CKDガイドライン改訂委員会：エビデンスに基づくCKD診療ガイドライン2013．東京医学社，東京，20138）Bakris GL, Williams M, Dworkin L, et al：Preserving renalfunction in adults with hypertension and diabetes：a consensusapproach. National Kidney Foundation Hypertension and DiabetesExecutive Committees Working Group. Am J KidneyDis 36：646-661, 20009）Jafar TH, Stark PC, Schmid CH, et al；AIPRD StudyGroup：Progression of chronic kidney disease：the role ofblood pressure control, proteinuria, and angiotensin convertingenzyme inhibition：a patient -level meta -analysis. AnnIntern Med 139：244-252, 200310）Bangalore S, Kumar S, Lobach I, et al：Blood pressure targetsin subjects with type 2 diabetes mellitus/impaired fastingglucose：observations from traditional and bayesian randomeffectsmeta-analyses of randomized trials. Circulation 123：2799-2810, 201111）Klahr S, Levey AS, Beck GJ, et al：The effects of dietaryprotein restriction and blood-pressure control on the progressionof chronic renal disease. Modification of Diet inRenal Disease Study Group. N Engl J Med 330：877-884,199412）Wright JT Jr, Bakris G, Greene T, et al：African AmericanStudy of Kidney Disease and Hypertension Study Group：Effect of blood pressure lowering and antihypertensive drugclass on progression of hypertensive kidney disease：resultsfrom the AASK trial. JAMA 288：2421-2431, 200213）Sarnak MJ, Greene T, Wang X, et al：The effect of a lowertarget blood pressure on the progression of kidney disease：long-term follow-up of the modification of diet in renal diseasestudy. Ann Intern Med 142：342-351, 200514）Appel LJ, Wright JT Jr, Greene T, et al；AASK CollaborativeResearch Group：Intensive blood-pressure control inhypertensive chronic kidney disease. N Engl J Med 363：918-929, 201015）Upadhyay A, Earley A, Haynes SM, et al：Systematicreview：blood pressure target in chronic kidney disease andproteinuria as an effect modifier. Ann Intern Med 154：541-548, 201116）Kokubo Y, Nakamura S, Okamura T, et al：Relationshipbetween blood pressure category and incidence of strokeand myocardial infarction in an urban Japanese populationwith and without chronic kidney disease：the Suita Study.Stroke 40：2674-2679, 200917）Khouri Y, Steigerwalt SP, Alsamara M, et al：What is theideal blood pressure goal for patients with stage Ⅲ or higherchronic kidney disease? Curr Cardiol Rep 13：492-501, 201118）Casas JP, Chua W, Loukogeorgakis S, et al：Effect of inhibitorsof the renin-angiotensin system and other antihypertensivedrugs on renal outcomes：systematic review and metaanalysis.Lancet 366：2026-2033, 200519）Rahman M, Ford CE, Cutler JA, et al；ALLHAT CollaborativeResearch Group：Long-term renal and cardiovascularoutcomes in Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack Trial（ALLHAT）participants bybaseline estimated GFR. Clin J Am Soc Nephrol 7：989-1002,2012